Literature DB >> 32385101

Rapid repurposing of drugs for COVID-19.

R Kiplin Guy1, Robert S DiPaola2, Frank Romanelli3, Rebecca E Dutch2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32385101     DOI： 10.1126/science.abb9332

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  85 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

2.  Interpretable network propagation with application to expanding the repertoire of human proteins that interact with SARS-CoV-2.

Authors:  Jeffrey N Law; Kyle Akers; Nure Tasnina; Catherine M Della Santina; Shay Deutsch; Meghana Kshirsagar; Judith Klein-Seetharaman; Mark Crovella; Padmavathy Rajagopalan; Simon Kasif; T M Murali
Journal:  Gigascience       Date:  2021-12-29       Impact factor: 6.524

3.  Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study.

Authors:  Shafi Mahmud; Suvro Biswas; Gobindo Kumar Paul; Mohasana Akter Mita; Shamima Afrose; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Mohammad Abu Raihan Uddin; Md Salah Uddin; Shahriar Zaman; K M Kaderi Kibria; Md Arif Khan; Talha Bin Emran; Md Abu Saleh
Journal:  Arab J Chem       Date:  2021-07-14       Impact factor: 5.165

4.  Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies.

Authors:  Shahzaib Ahamad; Hema Kanipakam; Shweta Birla; Md Shaukat Ali; Dinesh Gupta
Journal:  Eur J Pharmacol       Date:  2020-10-24       Impact factor: 4.432

5.  Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus.

Authors:  Qingxing Wang; Yun Luo; Weijuan Shang; Zhengli Shi; Gengfu Xiao; Leike Zhang
Journal:  Biosaf Health       Date:  2021-05-17

6.  An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19.

Authors:  Charles D Bengtson; Robert N Montgomery; Usman Nazir; Lewis Satterwhite; Michael D Kim; Nathan C Bahr; Mario Castro; Nathalie Baumlin; Matthias Salathe
Journal:  Front Med (Lausanne)       Date:  2021-02-17

7.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

8.  Major cardiac concerns in therapy and vaccinations for COVID-19.

Authors:  Syam Sundar Junapudi; Sunil Junapudi; Kishore Ega; Bojjibabu Chidipi
Journal:  Metabol Open       Date:  2021-06-29

9.  Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist.

Authors:  Seung-Hee Lee; Vimal Veeriah; Fred Levine
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

10.  Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study.

Authors:  Alfred Olaoluwa Akinlalu; Annapoorna Chamundi; Donald Terseer Yakumbur; Funmilayo I Deborah Afolayan; Ijeoma Akunna Duru; Michael Aderibigbe Arowosegbe; Ojochenemi Aladi Enejoh
Journal:  Sci Afr       Date:  2021-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.